India Globalization Capital, Inc.
India Globalization Capital, Inc. (NYSE:IGC) (FRA:IGS1) is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life-altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland.
Directions to listing
Send Message to listing owner
Listing Title: India Globalization Capital, Inc.